Neurocrine Biosciences Inc
Symbol: NBIX (NASDAQ)
142.06
▼ (-0.42%) -0.595
Company Description:
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Key Stats
- Today's Open: $141.581
- Today's High: $142.635
- Today's Low: $137.1
- Today's Volume: 12
- Yesterday Close: $142.65
- Yesterday High: $142.97
- Yesterday Low: $141.295
- Yesterday Volume: 511.73K
- Last Min Volume: 1
- Last Min High: $142.055
- Last Min Low: $142.055
- Last Min VWAP: $142.055
Company Profile
- Name: Neurocrine Biosciences Inc
- Website: https://www.neurocrine.com
- Listed Date: 1996-05-23
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0000914475
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $14.02B
- Round Lot: 100
- Outstanding Shares: 99.18M
- Asset Type: CS
RECENT FILINGS FOR NBIX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-11 | 4 | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | 144 | View |
| 2025-07-30 | 10-Q | View |
| 2025-07-30 | 8-K | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-10 | 144 | View |
| 2025-07-07 | 4 | View |
| 2025-07-02 | 144 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 3 | View |
| 2025-05-30 | 8-K | View |
| 2025-05-29 | 4 | View |
| 2025-05-27 | 144 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
Latest News on NBIX